bmiMD Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.2/10
Best for: starting below a standard dose, with microdose tiers
bmiMD scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on follow-up care. Its compounded semaglutide costs $129 a month, paid up front, 35% below the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
charged as a multi-month plan up front
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
bmiMD is a New York telehealth platform selling compounded semaglutide and tirzepatide, including microdose plans, in all 50 states. Dose does not change the price; plan length does. Month-to-month semaglutide costs $129; the $99 rate requires paying $1,188 for a 12-month plan up front.
Is bmiMD legit?
Yes. bmiMD is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 8.2/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a bmiMD promo or coupon code?
bmiMD has no code to type in. The current offer: bmiMD is currently running a sitewide sale of 20% off all products (auto-applied, no code). It applies at checkout on its own. Coupon sites advertising a "bmiMD promo code" are not a source we can vouch for.
See how bmiMD compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
What customers say about bmiMD
Praised for
- Fast delivery, often within a few days
- Quick, easy sign-up and approval
- Responsive, friendly customer service
Complained about
- Unexpected charges or renewals, and refunds not issued
- Hard to reach anyone; no phone line and slow email replies
- Vials seemed underfilled or the product seemed ineffective
Its reviews cover several products, not only GLP-1s, and most 5-star ones came in one invited burst in mid-2026. A summary of customer reviews on the sites linked above, read on the date shown. These are customers’ own accounts; they are not part of our score.
bmiMD at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $129/mo
- Pricing model
- Flat: the price stays the same as the dose goes up
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letters found
How bmiMD scores
Six columns, each one computed from something bmiMD has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
6.0/10$129/month is 35% below the $199 median for compounded semaglutide across the sellers we compare. Every standard-dose price requires paying for several months up front, so Value is capped at 6.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
8.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
10.0/10Serves all 50 states.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on bmiMD
Last checked October 2026- Checked the listed price across 4 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for bmiMD
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with bmiMD involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1bmiMD shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask bmiMD which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: semaglutide $129, tirzepatide $179. That leaves out membership fees, first-month rates and insurance copays.
- bmiMD serves all 50 states.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Cancelling bmiMD
Taken from the terms bmiMD publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None on monthly plans; longer plans are paid in full at checkout
- Refund policy
- Authorization hold released if not approved; $100 fee after intake; multi-month plans non-refundable
Medications bmiMD lists
bmiMD lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Peptides bmiMD offers
bmiMD sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
Plan picker: $129 for 1 month; $119/mo on 3 months ($357 up front), $109/mo on 6 ($654), $99/mo on 12 ($1,188). Provider visit and shipping included.
Plan picker: $179 for 1 month; $159/mo on 3 months ($477 up front), $149/mo on 6 ($894), $139/mo on 12 ($1,668).
First plan picker: $129 monthly, $119/mo on 3 months ($357), $109/mo on 6 ($654), $99/mo on 12 ($1,188). A second picker on the same page links to an uncouponed cart at $159 monthly.
Plan picker: $179 monthly, $159/mo on 3 months ($477), $149/mo on 6 ($894), $139/mo on 12 ($1,668).
Check the price yourself before you pay
Every figure here comes from bmiMD's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $129 a month, 35% below the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $179 a month, 33% below the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- We found no FDA warning letters issued to bmiMD
Against it
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What bmiMD charges
The standing price at bmiMD is $129/month, unchanged as the dose goes up. That sits at the affordable end of what we see. Flat dose pricing matters more than it sounds: on a tiered plan the bill grows with the dose, so the figure that got you to sign up is not the one you end up paying.
- Compounded semaglutide (injection): $129/month
- Compounded tirzepatide (injection): $179/month
- Compounded semaglutide (microdose injection): $129/month
- Compounded tirzepatide (microdose injection): $179/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so bmiMD's $129 is genuinely below the middle, not just advertised that way. Some of bmiMD's plans are paid several months up front, so read the terms you agree to at checkout before you choose a longer one.
Live Vital, at about $130/month, is the closest like-for-like alternative we review.
What bmiMD dispenses
bmiMD prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. The medication is compounded rather than dispensed as an approved pen. Compounding serves real clinical needs and is entirely lawful; what it is not is reviewed, and the cost difference reflects that. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder. bmiMD also lists a microdose plan, and the published evidence on GLP-1 microdosing is letters and commentary rather than trials.
Safety and disclosure
bmiMD tells you its price before you start the medical questionnaire and that it treats patients in all 50 states. We found no FDA warning letters issued to bmiMD. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If bmiMD will not tell you, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
bmiMD also sells NAD+, and a 2026 systematic review found no outcomes trials of injected NAD+ for anti-aging or wellness.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether bmiMD bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want the price to stop moving as your dose climbs
- you need access wherever you live
Our read
bmiMD competes on price without an obvious sacrifice elsewhere: $129/month, no FDA warning letters, and wide state coverage.
The Bottom Line
bmiMD scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on follow-up care. Its compounded semaglutide costs $129 a month, paid up front, 35% below the $199 median among the sellers we compare.
Before you pay bmiMD
Starting at $129 a month. Check today's price, then start the intake.
Where bmiMD is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to bmiMD sets more sellers in the same category beside bmiMD on price, states and what the price includes.
Alternatives to bmiMD
Editorial score · methodology
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Editorial score · methodology
Compare bmiMD head to head
Our head-to-head pages for bmiMD are bmiMD vs Gala, bmiMD vs Embody, bmiMD vs CoreAge Rx, bmiMD vs Direct Meds, and bmiMD vs SkinnyRx.
Frequently Asked Questions
How to check bmiMD yourself
- We Read FDA's Register of Compounding Facilities. 43 of 100 Have Never Been Inspected.
- How to Get a GLP-1 Prescription
- Is Ozempic Available Over the Counter? No GLP-1 Is, and What Is Sold Instead
Every seller that ships to your state, side by side: Alabama, Arkansas, Louisiana, Michigan, North Carolina, South Carolina, Virginia, Wisconsin and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this bmiMD review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See bmiMD's current pricing
Plans start at $129 a month. Whether you qualify is a clinician's decision, made after your intake.